ELEPSIA XR 1500 MG
- Product NDC
- 80705-101
- 11-digit product format
- 807050101
- Labeler code
- 80705
- Product ID
- 80705-101_3c463bee-1191-4cab-b4d0-367673db19ef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levetiracetam
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- TRIPOINT THERAPEUTICS, LLC
- Application
- NDA204417
- Marketing category
- NDA
- Marketing start
- 2021-02-12
- Substance
- LEVETIRACETAM
- Active strength
- 1500 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204417-001 | ELEPSIA XR | LEVETIRACETAM | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | |
| N204417-002 | ELEPSIA XR | LEVETIRACETAM | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204417-001 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | |
| N204417-001 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | |
| N204417-001 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | |
| N204417-001 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | |
| N204417-001 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | |
| N204417-002 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | |
| N204417-002 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | |
| N204417-002 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | |
| N204417-002 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | |
| N204417-002 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N204417-001 | ELEPSIA XR | 1GM | TABLET, EXTENDED RELEASE / ORAL | RLD | 2018-12-20 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N204417-002 | ELEPSIA XR | 1.5GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2018-12-20 | 3bdfa0b2c4d7… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204417-001 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-001 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-001 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-001 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-001 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-002 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-002 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-002 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-002 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204417-002 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-001 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-001 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-001 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-001 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-001 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-002 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-002 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-002 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-002 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204417-002 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-001 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-001 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-001 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-001 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-001 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-002 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-002 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-002 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-002 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204417-002 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-001 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-001 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-001 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-001 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-001 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-002 | 8425938 | 2026-02-22 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-002 | 8535717 | 2026-02-22 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-002 | 8163306 | 2027-09-03 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-002 | 8431156 | 2027-10-31 | Drug product | 2019-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204417-002 | 8470367 | 2027-10-31 | Drug product | 2019-01-11 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ELEPSIA XR 1500 MG
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVETIRACETAM | 1500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44YRR34555 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| cac83d47-88a2-4447-a0c0-90b44ffda0ac | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 76e81f18-c6b9-f226-530a-a6296d5cd5f4 | Product name | 6 | 20251106 |
| 087c9486-f4a9-a565-c6fb-d6fa49f4572a | Product name | 6 | 20230317 |
| 525a8d4d-1988-fc3f-e292-27fd384de4f0 | Product name | 8 | 20230104 |
| 32b651f8-caa7-6882-11c7-54c4ad21796b | Product name | 8 | 20201216 |
| ce453ca5-90cf-41ed-9de4-de519f70a0f2 | Product name | 2 | 20160303 |
| 66666eb8-1fa6-4a60-bae9-e564e73b4cd5 | Product name | 1 | 20150728 |
| eecbc0ef-ab5c-4ff9-8aaa-6ea73ee46477 | Product name | 1 | 20150410 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80705-101-02 | ELEPSIA XR 1500 MG | 2 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 2 | 5 | |
| 80705-101-02 | ELEPSIA XR 1500 MG | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 5 | |
| 80705-101-30 | ELEPSIA XR 1500 MG | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | 5 | |
| 80705-101-99 | ELEPSIA XR 1500 MG | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 5 | |
| 80705-101-99 | ELEPSIA XR 1500 MG | 7 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 7 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80705-101-30 | EA - Each | 80705-101 | ef4d995c-8def-429f-a237-d57e1a44821d | 1 | 2021-04-08 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80705-101 | ELEPSIA XR 1000 MG (LEVETIRACETAM) TABLET, EXTENDED RELEASE ELEPSIA XR 1500 MG (LEVETIRACETAM) TABLET, EXTENDED RELEASE [TRIPOINT THERAPEUTICS, LLC] | 5 | Current NDC, Legacy NDC, 5 package rows | 20240328_cac83d47-88a2-4447-a0c0-90b44ffda0ac.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELEPSIA XR 1000 MG | LEVETIRACETAM | TRIPOINT THERAPEUTICS, LLC | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 2024-03-25 | Warnings, Adverse reactions | 204417 NDA204417 80705-101 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | PSN | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | PSN | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | PSN | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | PSN | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605368 | 24 HR levetiracetam 1000 MG Extended Release Oral Tablet [Elepsia] | SBD | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605374 | 24 HR levetiracetam 1500 MG Extended Release Oral Tablet [Elepsia] | SBD | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605362 | 24 HR levetiracetam 1000 MG Extended Release Oral Tablet | SCD | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605372 | 24 HR levetiracetam 1500 MG Extended Release Oral Tablet | SCD | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605368 | 24 HR Elepsia 1000 MG Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605374 | 24 HR Elepsia 1500 MG Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605368 | Elepsia XR 1000 MG 24 HR Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605374 | Elepsia XR 1500 MG 24 HR Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605362 | levetiracetam 1000 MG 24 HR Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
| 1605372 | levetiracetam 1500 MG 24 HR Extended Release Oral Tablet | SY | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 80705-101-02 | 80705010102 | 1 BLISTER PACK in 1 CARTON (80705-101-02) / 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 1 blister pack | 2021-09-29 | 0000-00-00 | No | No | Current |
| 80705-101-30 | 80705010130 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80705-101-30) | 2021-02-12 | 0000-00-00 | No | No | Current | |
| 80705-101-99 | 80705010199 | 1 BLISTER PACK in 1 CARTON (80705-101-99) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 1 blister pack | 2021-02-12 | 0000-00-00 | No | No | Current |